The three metabolisms of α-synuclein, amyloid β (Aβ), and hyperphosphorylated Tau protein (p-Tau) are suggested as major mechanisms by which TKIs are associated with the lower risk of dementia and PD. The gene discussed is MAPT; the disease is dementia.